GRP
AMPH icon

Global Retirement Partners’s Amphastar Pharmaceuticals AMPH Stock Holding History

Global Retirement Partners’s Portfolio AMPH Stock Details AMPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$31.4K Buy
1,174
+150
+15% +$3.86K ﹤0.01% 2639
2025
Q3 		$27.3K Buy
1,024
+703
+219% +$18.2K ﹤0.01% 2248
2025
Q2 		$7.37K Buy
+321
New +$7.97K ﹤0.01% 2740
2024
Q4 		$6.54K Buy
176
+6
+4% +$274 ﹤0.01% 2565
2024
Q3 		$8.25K Sell
170
-22
-11% -$965 ﹤0.01% 2366
2024
Q2 		$7.68K Buy
192
+145
+309% +$6.01K ﹤0.01% 2429
2024
Q1 		$2.06K Sell
47
-49
-51% -$2.53K ﹤0.01% 2742
2023
Q4 		$5.33K Buy
96
+68
+243% +$3.57K ﹤0.01% 2298
2023
Q3 		$1.28K Buy
28
+2
+8% +$109 ﹤0.01% 2697
2023
Q2 		$1.49K Buy
26
+15
+136% +$665 ﹤0.01% 2648
2023
Q1 		$399 Hold
11
– – ﹤0.01% 2972
2022
Q4 		$308 Hold
11
– – ﹤0.01% 2866
2022
Q3 		$0 Buy
11
+3
+38% +$98 ﹤0.01% 2673
2022
Q2 		$0 Buy
+8
New +$285 ﹤0.01% 2663

Other funds holding AMPH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $123B AUM 34.51% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
EIP
Epoch Investment Partners New York $16.5B AUM 24.3% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Global Retirement Partners's AMPH Position: Q4 2025 in Review

Global Retirement Partners increased its Amphastar Pharmaceuticals (AMPH) stake by 15% in Q4 2025, buying an estimated $3.86K and bringing the position to 1,174 shares worth $31.4K. The position accounts for ﹤0.01% of the portfolio, ranked #2639.

Global Retirement Partners first reported a position in AMPH in Q2 2022 and has held it in 14 quarters since. 235 funds tracked by Wall St. Rank hold AMPH as of Q4 2025.

  • Global Retirement Partners held 1,174 shares of Amphastar Pharmaceuticals worth $31.4K as of Q4 2025.
  • Global Retirement Partners bought 150 Amphastar Pharmaceuticals shares in Q4 2025, an estimated $3.86K.
  • Amphastar Pharmaceuticals made up ﹤0.01% of Global Retirement Partners's portfolio in Q4 2025, its #2639 holding.
  • Global Retirement Partners first reported a position in Amphastar Pharmaceuticals in Q2 2022 and has held it in 14 quarters since.
  • 235 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q4 2025.

Based on Global Retirement Partners's 13F filing for Q4 2025, filed 6 Feb 2026.